Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FWJA8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,692
Award facts
- Contract value 100% obligated
- $20,691.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,691.96 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor that supplies a broad range of medications, vaccines, medical devices, and healthcare commodities to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. The Gemtesa delivery order represents one of many task orders executed under the master contract vehicle, supporting the Defense Health Agency and other government healthcare systems' prescription medication needs.
Quick answers
Who was awarded contract SPE2DR26FWJA8?
SPE2DR26FWJA8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FWJA8 worth?
The government has obligated $20,692 on SPE2DR26FWJA8.
Is contract SPE2DR26FWJA8 an order under another contract?
Yes. SPE2DR26FWJA8 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWJA8 competed?
The extent of competition for SPE2DR26FWJA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award